Back to Search
JAMES MARTENSON, M.D.
M.D.
Radiation Oncology Physician
NPI: 1679550958Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
27169(MN)23272(WI)81233(WI)
Research & Publications (20)
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.
PMID 18768432·J Clin Oncol·2008
3-trial
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
PMID 15249584·J Clin Oncol·2004
3-trial
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
PMID 12654442·Int J Radiat Oncol Biol Phys·2003
3-trial
Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial.
PMID 10715293·J Clin Oncol·2000
3-trial
Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer.
PMID 18430106·Dis Esophagus·2008
8-other
Subspecies genetic assignments of worldwide captive tigers increase conservation value of captive populations.
PMID 18424146·Curr Biol·2008
7-preclinical
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
PMID 17921712·Am J Clin Oncol·2007
3-trial
Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
PMID 17577035·J Clin Oncol·2007
3-trial
Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial.
PMID 17401014·J Clin Oncol·2007
3-trial
A highly diastereoselective, catalytic three-component assembly reaction for the synthesis of spiropyrrolidinyloxindoles.
PMID 17264914·Chem Commun (Camb)·2007
8-other
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
PMID 16877719·J Clin Oncol·2006
3-trial
Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.
PMID 16848974·Hum Genomics·2006
8-other
Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy.
PMID 16770786·Cancer·2006
8-other
Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland.
PMID 15590182·Int J Radiat Oncol Biol Phys·2004
8-other
Phylogeography and genetic ancestry of tigers (Panthera tigris).
PMID 15583716·PLoS Biol·2004
7-preclinical
Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group.
PMID 15533252·Int Semin Surg Oncol·2004
8-other
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
PMID 15254061·J Clin Oncol·2004
6-review
Prevalence of Bartonella infection in wild African lions (Panthera leo) and cheetahs (Acinonyx jubatus).
PMID 15135511·Vet Microbiol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1679550958
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile